Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2009, Article ID 538081, 4 pages
http://dx.doi.org/10.1155/2009/538081
Case Report

Effective Monotherapy with Amrubicin for a Refractory Extrapulmonary Small-Cell Carcinoma of the Liver

1Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-Ku, Fukuoka 812-8582, Japan
2Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-Ku, Fukuoka 812-8582, Japan
3Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-Ku, Fukuoka 812-8582, Japan

Received 7 February 2009; Accepted 19 May 2009

Academic Editor: Ramsey Cheung

Copyright © 2009 Taichi Isobe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Remick and J. C. Ruckdeschel, “Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome,” Medical and Pediatric Oncology, vol. 20, no. 2, pp. 89–99, 1992. View at Publisher · View at Google Scholar
  2. R. M. Levenson, Jr., D. C. Ihde, M. J. Matthews et al., “Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy,” Journal of the National Cancer Institute, vol. 67, no. 3, pp. 607–612, 1981. View at Google Scholar
  3. J. H. Kim, S.-H. Lee, J. Park et al., “Extrapulmonary small-cell carcinoma: a single-institution experience,” Japanese Journal of Clinical Oncology, vol. 34, no. 5, pp. 250–254, 2004. View at Publisher · View at Google Scholar
  4. R. L. Richardson and L. H. Weiland, “Undifferentiated small cell carcinomas in extrapulmonary sites,” Seminars in Oncology, vol. 9, no. 4, pp. 484–496, 1982. View at Google Scholar
  5. S. Onoda, N. Masuda, T. Seto et al., “Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: thoracic oncology research group study 0301,” Journal of Clinical Oncology, vol. 24, no. 34, pp. 5448–5453, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. M. Hanada, S. Mizuno, A. Fukushima, Y. Saito, T. Noguchi, and T. Yamaoka, “A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex,” Japanese Journal of Cancer Research, vol. 89, no. 11, pp. 1229–1238, 1998. View at Google Scholar
  7. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar
  8. M. Sengoz, U. Abacioglu, T. Salepci, F. Eren, F. Yumuk, and S. Turhal, “Extrapulmonary small cell carcinoma: multimodality treatment results,” Tumori, vol. 89, no. 3, pp. 274–277, 2003. View at Google Scholar
  9. F. Zanconati, G. Falconieri, J. Lamovec, and A. Zidar, “Small cell carcinoma of the liver: a hitherto unreported variant of hepatocellular carcinoma,” Histopathology, vol. 29, no. 5, pp. 449–453, 1996. View at Google Scholar
  10. Y. H. Kim, R. Kwon, G. J. Jung et al., “Extrapulmonary small-cell carcinoma of the liver,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 11, no. 5, pp. 333–337, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. S. J. Choi, J. M. Kim, J. Y. Han et al., “Extrapulmonary small cell carcinoma of the liver: clinicopathological and immunohistochemical findings,” Yonsei Medical Journal, vol. 48, no. 6, pp. 1066–1071, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. S. C. Remick, G. R. Hafez, and P. P. Carbone, “Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome,” Medicine, vol. 66, no. 6, pp. 457–471, 1987. View at Google Scholar
  13. E. Galanis, S. Frytak, and R. V. Lloyd, “Extrapulmonary small cell carcinoma,” Cancer, vol. 79, no. 9, pp. 1729–1736, 1997. View at Publisher · View at Google Scholar
  14. B. Brenner, L. H. Tang, D. S. Klimstra, and D. P. Kelsen, “Small-cell carcinomas of the gastrointestinal tract: a review,” Journal of Clinical Oncology, vol. 22, no. 13, pp. 2730–2739, 2004. View at Publisher · View at Google Scholar · View at PubMed
  15. B. E. Johnson, J. Whang-Peng, S. L. Naylor et al., “Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies,” Journal of the National Cancer Institute, vol. 81, no. 16, pp. 1223–1228, 1989. View at Google Scholar
  16. K. Takubo, K.-I. Nakamura, M. Sawabe et al., “Primary undifferentiated small cell carcinoma of the esophagus,” Human Pathology, vol. 30, no. 2, pp. 216–221, 1999. View at Publisher · View at Google Scholar
  17. K. Noda, Y. Nishiwaki, M. Kawahara et al., “Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer,” The New England Journal of Medicine, vol. 346, no. 2, pp. 85–91, 2002. View at Publisher · View at Google Scholar · View at PubMed
  18. Y. Ohe, S. Negoro, K. Matsui et al., “Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer,” Annals of Oncology, vol. 16, no. 3, pp. 430–436, 2005. View at Publisher · View at Google Scholar · View at PubMed